Inhibition and Formation of Amyloid Fibrils in the Bulk and at the Interface of Biomolecular Condensates

ABSTRACT Cells can form open compartments, known as biomolecular condensates, which possess distinct environments and concentrations compared to their surroundings. These biomolecular condensates can modulate biochemical processes, including protein aggregation. Notably, they have been reported to both accelerate and inhibit protein aggregation. Since protein aggregation is often associated with pathological conditions like neurodegenerative diseases, it is crucial to understand the molecular mechanisms underlying the interplay between phase separation and fibril formation. In this review, we discuss how, contrary to intuition, aggregation within the bulk of condensates can be inhibited rather than promoted, even in the presence of elevated local protein concentration. However, biomolecular condensates can still facilitate fibril formation by generating an interface between the dense and dilute phases, where molecular and mesoscale properties are optimal for the nucleation of protein aggregation.

Authors

Institutions

Publication Details

Journal
Angewandte Chemie
Published
2026-06-26
DOI
https://doi.org/10.1002/ange.202515409
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Inhibition and Formation of Amyloid Fibrils in the Bulk and at the Interface of Biomolecular Condensates

Sarah Khawaja, Paolo Arosio, Chiara Morelli, M Papp
Angewandte Chemie
Alzheimer's disease research and treatments
article

Inhibition and Formation of Amyloid Fibrils in the Bulk and at the Interface of Biomolecular Condensates

Sarah Khawaja, Paolo Arosio, Chiara Morelli, M Papp
article en

Abstract

ABSTRACT Cells can form open compartments, known as biomolecular condensates, which possess distinct environments and concentrations compared to their surroundings. These biomolecular condensates can modulate biochemical processes, including protein aggregation. Notably, they have been reported to both accelerate and inhibit protein aggregation. Since protein aggregation is often associated with pathological conditions like neurodegenerative diseases, it is crucial to understand the molecular mechanisms underlying the interplay between phase separation and fibril formation. In this review, we discuss how, contrary to intuition, aggregation within the bulk of condensates can be inhibited rather than promoted, even in the presence of elevated local protein concentration. However, biomolecular condensates can still facilitate fibril formation by generating an interface between the dense and dilute phases, where molecular and mesoscale properties are optimal for the nucleation of protein aggregation.

Angewandte Chemie
ETH Zurich (CH), Institute for Biomedical Engineering (CH)
European Research Council
Openalex Percentile: Top 7%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Inhibition and Formation of Amyloid Fibrils in the Bulk and at the Interface of Biomolecular Condensates — Sarah Khawaja, Paolo Arosio, et al. · Angewandte Chemie (2026) | TGRS Research Map | TGRS